Abstract:Introduction: Although COVID-19 is mainly a respiratory disease, recent evidence has emerged of vascular and procoagulant pathologies even in young and otherwise healthy individuals. Ophthalmic manifestations include, among others, visual impairment due to arteritic and venous retinal obstructions, which at times precedes other aspects of the disease. We present two atypical cases of internal carotid dissection (ICAD) and review the different ocular symptoms of ICAD and its association with the COVID-19 pandemic. Background: A 43-year-old otherwise healthy man was referred to the Emergency Department with a headache and monocular blurring of vision. A recent fever (2 weeks prior) was noted on anamnesis, in light of absence of available positive PCR test during the illness period, clinical suspicion of COVID-19 was assumed. An initial ophthalmic evaluation found a mild optic nerve function impairment with preserved visual acuity. Computed tomography (CT) showed sinusitis, and an initial diagnosis was made of mild optic neuropathy secondary to sphenoid sinusitis. A few hours after admission, the patient reported deterioration of symptoms and examination revealed no light perception in his right eye and pale edematous optic nerve. Urgent magnetic resonance angiography (MRA) demonstrated right ICAD with no additional findings. The second patient, a 43-year-old man developed an acute event of strabismus, left limb paralysis, and speech difficulties while on a hospital visit for his son. The patient underwent CT of the brain which demonstrated extensive infarction following the distribution of his right cerebral artery. Continued investigation using computed tomography angiography (CTA) demonstrated a dissection of the right internal carotid artery. The patient was positive for COVID-19. Discussion: In this review, we discuss 2 cases of carotid artery dissection presenting with an acute ocular complaint in two otherwise healthy young individuals. Events were suspected to have been provoked by COVID-19 infection. The pathogenesis and mechanisms behind COVID-19 induced coagulopathy are not clear, and several mechanisms have been proposed including endothelial damage and dysfunction. The virus is thought to enter endothelial cells and lead to a pathological procoagulant state. Awareness should be drawn to uncommon signs especially in young adults. Clotting issues can arise and should be treated quickly as they might be life and vision threatening.

Scalp capillarectasia as a trichoscopic sign of COVID‐19‐associated telogen effluvium

Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes

The Role of Autologous Micrografts Injection from The Scalp Tissue in The Treatment of Covid‐19 Associated Telogen Effluvium: Clinical and Trichoscopic Evaluation

Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity

Post-COVID Telogen Effluvium.

SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation

Telogen effluvium in the new SARS‐CoV‐2 era

[Review of the post-COVID-19 syndrome associated to acute telogen effluvium]

Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women

Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management

A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital

Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19

Impact of the COVID-19 pandemic on telogen effluvium: a nationwide multicentre interrupted time series study

Efficacy of Dr. SKS hair booster serum for the treatment of hair loss in COVID-19 induced persistent telogen effluvium

Evaluation of Ocular Symptoms and Tropism of SARS‐CoV‐2 in Patients Confirmed with COVID‐19

Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations

[VASCULAR OPHTHALMIC MANIFESTATIONS IN COVID-19 PATIENTS]

Telogen effluvium revisited

Characteristics of hair loss in COVID-19 patients in Thailand

CT features of coronavirus disease 2019 (COVID-19) with an emphasis on the vascular enlargement pattern

COMPARATIVE ANALYSIS OF THE IMPACT OF COVID-19 INFECTION AND GENERAL SOMATIC DISEASES TO TELOGEN HAIR LOSS